Sort
78,016 grants matching “breast cancer”
Molecular Mammography of Her-2 Cancers using Gold Nanoparticles
$474,069James F. Hainfeld · Nanoprobes, Inc. · R44 · FY2008 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$474,024Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain
$474,022Jing Wang · New York University School Of Medicine · UH3 · FY2024 · CA
TARGETING ESR1-MUTANT BREAST CANCER
$474,000University Of Chicago · · FY2014 · Department of Defense
MICROBIOME-DERIVED TRNA Q MODIFICATIONS MEDIATE BREAST CANCER BIOLOGY
$474,000University Of Chicago · · FY2017 · Department of Defense
MOLECULAR DETERMINANTS AND CLINICAL IMPLICATIONS OF BREAST CANCER DORMANCY
$474,000The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2012 · Department of the Army
PREDICTING AND UNDERSTANDING PATIENT RESPONSES TO TOPOII ISOMERASE INHIBITORS IN BREAST CANCER
$474,000The Leland Stanford Junior University · · FY2016 · Department of the Army
TARGETING BREAST CANCER WITH A STEROID ADAPTER TO INHIBIT DNA REPAIR
$473,998The Leland Stanford Junior University · · FY2008 · Department of the Army
14-3-3 ZETA MRNA-MEDIATED MIRNA SPONGING AND ITS ROLE IN BREAST CANCER PROGRESSION AND METASTASIS
$473,986The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2013 · Department of Defense
Project 2: Combination immunotherapy approaches to overcome therapeutic resistance in HER2-positive breast cancer
$473,960Ian E Krop · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2020 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$473,941Paul Mathew · Tufts Medical Center · R01 · FY2021 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$473,937Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
STRATEGIC STUDIES IN BREAST CANCER SURVEILLANCE
$473,927Dartmouth College · U01 · FY2001 · CA
High Throughput Sequencer
$473,927William Richard McCombie · Cold Spring Harbor Laboratory · S10 · FY2007 · RR
Greater Denver Latino Cancer Prevention/Control Network
$473,907Paula A Espinoza · University Of Colorado Denver/Hsc Denver · U01 · FY2007 · CA
Cancer Care Delivery in Medicaid
$473,906Deborah Schrag · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Integrating Mammograms in Analyses of Genes and Environment in Sisters (IMAGES)
$473,906Parisa Tehranifar · Columbia University Health Sciences · U01 · FY2019 · CA
HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities
$473,901Andrew P Hinck · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer
$473,860Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Structure and Function of Integral Membrane Enzyme Human Aromatase
$473,854Debashis Ghosh · Hauptman-Woodward Medical Research Inst · R01 · FY2009 · GM
Image-guided EMT inhibition for treating metastatic breast cancer
$473,853Zheng-Rong Lu · Case Western Reserve University · R01 · FY2016 · CA
Image-guided EMT inhibition for treating metastatic breast cancer
$473,853Zheng-Rong Lu · Case Western Reserve University · R01 · FY2015 · CA
Image-guided EMT inhibition for treating metastatic breast cancer
$473,853Zheng-Rong Lu · Case Western Reserve University · R01 · FY2017 · CA
Image-guided EMT inhibition for treating metastatic breast cancer
$473,853Zheng-Rong Lu · Case Western Reserve University · R01 · FY2018 · CA